These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 26049667)
1. LRG1 modulates invasion and migration of glioma cell lines through TGF-β signaling pathway. Zhong D; He G; Zhao S; Li J; Lang Y; Ye W; Li Y; Jiang C; Li X Acta Histochem; 2015 Jul; 117(6):551-8. PubMed ID: 26049667 [TBL] [Abstract][Full Text] [Related]
2. TGF-β1 promotes motility and invasiveness of glioma cells through activation of ADAM17. Lu Y; Jiang F; Zheng X; Katakowski M; Buller B; To SS; Chopp M Oncol Rep; 2011 May; 25(5):1329-35. PubMed ID: 21359495 [TBL] [Abstract][Full Text] [Related]
3. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202 [TBL] [Abstract][Full Text] [Related]
4. Ionizing radiation promotes migration and invasion of cancer cells through transforming growth factor-beta-mediated epithelial-mesenchymal transition. Zhou YC; Liu JY; Li J; Zhang J; Xu YQ; Zhang HW; Qiu LB; Ding GR; Su XM; Mei-Shi ; Guo GZ Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1530-7. PubMed ID: 22115555 [TBL] [Abstract][Full Text] [Related]
5. EWI-2 negatively regulates TGF-β signaling leading to altered melanoma growth and metastasis. Wang HX; Sharma C; Knoblich K; Granter SR; Hemler ME Cell Res; 2015 Mar; 25(3):370-85. PubMed ID: 25656846 [TBL] [Abstract][Full Text] [Related]
6. SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility. Hjelmeland MD; Hjelmeland AB; Sathornsumetee S; Reese ED; Herbstreith MH; Laping NJ; Friedman HS; Bigner DD; Wang XF; Rich JN Mol Cancer Ther; 2004 Jun; 3(6):737-45. PubMed ID: 15210860 [TBL] [Abstract][Full Text] [Related]
7. Leucine rich α2 glycoprotein 1 derived from malignant pleural mesothelioma cells facilitates macrophage M2 phenotypes. Wang D; Pei W; Liu Y; Mo R; Li X; Gu W; Su Y; Ye J; Xu J; Zhao D Exp Lung Res; 2024; 50(1):136-145. PubMed ID: 39033404 [No Abstract] [Full Text] [Related]
8. LRG1 modulates epithelial-mesenchymal transition and angiogenesis in colorectal cancer via HIF-1α activation. Zhang J; Zhu L; Fang J; Ge Z; Li X J Exp Clin Cancer Res; 2016 Feb; 35():29. PubMed ID: 26856989 [TBL] [Abstract][Full Text] [Related]
9. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor. Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491 [TBL] [Abstract][Full Text] [Related]
10. Transforming Growth Factor-β Is an Upstream Regulator of Mammalian Target of Rapamycin Complex 2-Dependent Bladder Cancer Cell Migration and Invasion. Gupta S; Hau AM; Al-Ahmadie HA; Harwalkar J; Shoskes AC; Elson P; Beach JR; Hussey GS; Schiemann WP; Egelhoff TT; Howe PH; Hansel DE Am J Pathol; 2016 May; 186(5):1351-60. PubMed ID: 26988652 [TBL] [Abstract][Full Text] [Related]
11. MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway. Lynch J; Fay J; Meehan M; Bryan K; Watters KM; Murphy DM; Stallings RL Carcinogenesis; 2012 May; 33(5):976-85. PubMed ID: 22382496 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of transforming growth factor-β signaling potentiates tumor cell invasion into collagen matrix induced by fibroblast-derived hepatocyte growth factor. Oyanagi J; Kojima N; Sato H; Higashi S; Kikuchi K; Sakai K; Matsumoto K; Miyazaki K Exp Cell Res; 2014 Aug; 326(2):267-79. PubMed ID: 24780821 [TBL] [Abstract][Full Text] [Related]
14. Effects of transforming growth factor-β inhibitor on the proliferation of glioma stem/progenitor cell. Zhang Q; Guo W; Di C; Lou M; Li H; Zhao Y Pol J Pathol; 2017; 68(4):312-317. PubMed ID: 29517201 [TBL] [Abstract][Full Text] [Related]
15. Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines. Ohta M; Abe A; Ohno F; Hasegawa Y; Tanaka H; Maseki S; Kondo E; Kurita K; Nakanishi H Oral Oncol; 2013 Jan; 49(1):20-6. PubMed ID: 22840788 [TBL] [Abstract][Full Text] [Related]
16. The role of leucine-rich alpha-2-glycoprotein-1 in proliferation, migration, and invasion of tumors. Lin M; Liu J; Zhang F; Qi G; Tao S; Fan W; Chen M; Ding K; Zhou F J Cancer Res Clin Oncol; 2022 Feb; 148(2):283-291. PubMed ID: 35037101 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of TGF-β Signaling in Gliomas by the Flavonoid Diosmetin Isolated from Yan Y; Liu X; Gao J; Wu Y; Li Y Molecules; 2020 Jan; 25(1):. PubMed ID: 31906574 [No Abstract] [Full Text] [Related]
19. LRG1 loss effectively restrains glomerular TGF-β signaling to attenuate diabetic kidney disease. Wang X; Sun Z; Fu J; Fang Z; Zhang W; He JC; Lee K Mol Ther; 2024 Sep; 32(9):3177-3193. PubMed ID: 38910328 [TBL] [Abstract][Full Text] [Related]
20. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas. Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]